{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:25:59Z","timestamp":1788967559193,"version":"build-2803163510"},"reference-count":184,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010090","name":"Women and Children's Health Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019691","name":"Faculty of Medicine and Dentistry, University of Alberta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000190","name":"University of Alberta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.cjca.2025.01.029","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T17:26:42Z","timestamp":1738258002000},"page":"1699-1714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Impact of Obesity on Cardiac Energy Metabolism and Efficiency in Heart Failure With Preserved Ejection Fraction"],"prefix":"10.1016","volume":"41","author":[{"given":"Ezra B.","family":"Ketema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1010-0454","authenticated-orcid":false,"given":"Gary D.","family":"Lopaschuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2025.01.029_bib1","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular disease: a scientific statement from the American Heart Association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.01.029_bib2","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.120.316101","article-title":"Obesity phenotypes, diabetes, and cardiovascular diseases","volume":"126","author":"Pich\u00e9","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2025.01.029_bib3","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jacc.2022.11.031","article-title":"Challenges in cardiovascular evaluation and management of obese patients: JACC state-of-the-art review","volume":"81","author":"Bianchettin","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.01.029_bib4","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1093\/cvr\/cvac120","article-title":"Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets","volume":"118","author":"Borlaug","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2025.01.029_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/CIRCULATIONAHA.117.028365","article-title":"Obese heart failure with preserved ejection fraction phenotype: from pariah to central player","volume":"136","author":"Kitzman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.01.029_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1124\/jpet.123.001791","article-title":"Obesity is a major determinant of impaired cardiac energy metabolism in heart failure with preserved ejection fraction","volume":"388","author":"G\u00fcven","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cjca.2025.01.029_bib7","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3390\/jcm13051195","article-title":"Myocardial metabolism in heart failure with preserved ejection fraction","volume":"13","author":"Henry","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.cjca.2025.01.029_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.31083\/j.rcm2509311","article-title":"Potential mechanisms of epicardial adipose tissue influencing heart failure with preserved ejection fraction","volume":"25","author":"Li","year":"2024","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.cjca.2025.01.029_bib9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/CIRCRESAHA.107.150417","article-title":"Cardiac energy metabolism in obesity","volume":"101","author":"Lopaschuk","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2025.01.029_bib10","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1161\/CIRCRESAHA.116.306206","article-title":"Insulin signaling and heart failure","volume":"118","author":"Riehle","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2025.01.029_bib11","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.2337\/db14-1050","article-title":"Lowering body weight in obese mice with diastolic heart failure improves cardiac insulin sensitivity and function: implications for the obesity paradox","volume":"64","author":"Sankaralingam","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.cjca.2025.01.029_bib12","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1111\/dom.13762","article-title":"Weight loss enhances cardiac energy metabolism and function in heart failure associated with obesity","volume":"21","author":"Karwi","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.cjca.2025.01.029_bib13","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","article-title":"The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus","volume":"281","author":"Randle","year":"1963","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2025.01.029_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","article-title":"Myocardial fatty acid metabolism in health and disease","volume":"90","author":"Lopaschuk","year":"2010","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cjca.2025.01.029_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fcvm.2018.00068","article-title":"Loss of metabolic flexibility in the failing heart","volume":"5","author":"Karwi","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cjca.2025.01.029_bib16","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac energy metabolism in heart failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2025.01.029_bib17","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1017\/S000711450000088X","article-title":"Obesity, insulin resistance and diabetes\u2014a worldwide epidemic","volume":"83","author":"Seidell","year":"2000","journal-title":"Br J Nutr"},{"key":"10.1016\/j.cjca.2025.01.029_bib18","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1161\/01.CIR.0000127959.28627.F8","article-title":"Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women","volume":"109","author":"Peterson","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.01.029_bib19","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1161\/01.RES.61.6.853","article-title":"Metabolism of palmitate in isolated working hearts from spontaneously diabetic \u201cBB\u201d Wistar rats","volume":"61","author":"Lopaschuk","year":"1987","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2025.01.029_bib20","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.2337\/diabetes.53.9.2366","article-title":"Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob\/ob mouse hearts","volume":"53","author":"Mazumder","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.cjca.2025.01.029_bib21","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1210\/en.2005-0938","article-title":"Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity","volume":"146","author":"Buchanan","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.cjca.2025.01.029_bib22","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00395-011-0156-1","article-title":"A high fat diet increases mitochondrial fatty acid oxidation and uncoupling to decrease efficiency in rat heart","volume":"106","author":"Cole","year":"2011","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.cjca.2025.01.029_bib23","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1161\/CIRCULATIONAHA.108.832915","article-title":"Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity","volume":"119","author":"Yan","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.01.029_bib24","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.molmet.2015.01.005","article-title":"Therapeutic effects of adropin on glucose tolerance and substrate utilization in diet-induced obese mice with insulin resistance","volume":"4","author":"Gao","year":"2015","journal-title":"Mol Metab"},{"key":"10.1016\/j.cjca.2025.01.029_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s40168-021-01097-8","article-title":"Novel insights into the genetically obese (ob\/ob) and diabetic (db\/db) mice: two sides of the same coin","volume":"9","author":"Suriano","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.cjca.2025.01.029_bib26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0006-291X(76)90255-2","article-title":"Insulin's effect on glucose oxidation independent of glucose transport","volume":"71","author":"Olefsky","year":"1976","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cjca.2025.01.029_bib27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/cvr\/cvu156","article-title":"Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling","volume":"103","author":"Alrob","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2025.01.029_bib28","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.bbalip.2016.03.020","article-title":"Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes","volume":"1861","author":"Fukushima","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cjca.2025.01.029_bib29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/oby.22038","article-title":"Bariatric surgery-induced cardiac and lipidomic changes in obesity-related heart failure with preserved ejection fraction","volume":"26","author":"Mikhalkova","year":"2018","journal-title":"Obesity"},{"key":"10.1016\/j.cjca.2025.01.029_bib30","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/oby.2011.186","article-title":"Myocardial oxygen consumption change predicts left ventricular relaxation improvement in obese humans after weight loss","volume":"19","author":"Lin","year":"2011","journal-title":"Obesity"},{"key":"10.1016\/j.cjca.2025.01.029_bib31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.biochi.2015.10.024","article-title":"Adipocyte lipolysis and insulin resistance","volume":"125","author":"Morigny","year":"2016","journal-title":"Biochimie"},{"key":"10.1016\/j.cjca.2025.01.029_bib32","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/ejhf.600","article-title":"Reframing the association and significance of co-morbidities in heart failure","volume":"18","author":"Triposkiadis","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2025.01.029_bib33","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart\u2014an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.01.029_bib34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","article-title":"Nitrosative stress drives heart failure with preserved ejection fraction","volume":"568","author":"Schiattarella","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.cjca.2025.01.029_bib35","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/CIRCRESAHA.120.317933","article-title":"Targeting mitochondria-inflammation circuit by \u03b2-hydroxybutyrate mitigates HFpEF","volume":"128","author":"Deng","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2025.01.029_bib36","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.ajpath.2020.04.006","article-title":"Mouse models of heart failure with preserved or reduced ejection fraction","volume":"190","author":"Noll","year":"2020","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cjca.2025.01.029_bib37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10741-023-10371-w","article-title":"Large animal models to study effectiveness of therapy devices in the treatment of heart failure with preserved ejection fraction (HFpEF)","volume":"29","author":"Fisher","year":"2024","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cjca.2025.01.029_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41401-023-01152-0","article-title":"Animal models of heart failure with preserved ejection fraction (HFpEF): from metabolic pathobiology to drug discovery","volume":"45","author":"Gao","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.cjca.2025.01.029_bib39","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jacbts.2017.07.013","article-title":"Murine models of heart failure with preserved ejection fraction: a \u201cfishing expedition.\u201d","volume":"2","author":"Valero-Mu\u00f1oz","year":"2017","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.cjca.2025.01.029_bib40","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1161\/CIRCRESAHA.120.317046","article-title":"NAD+ repletion reverses heart failure with preserved ejection fraction","volume":"128","author":"Tong","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2025.01.029_bib41","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/CIRCULATIONAHA.122.061846","article-title":"Myocardial metabolomics of human heart failure with preserved ejection fraction","volume":"147","author":"Hahn","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.01.029_bib42","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1002\/ejhf.3432","article-title":"Glycolysis in heart failure with preserved ejection fraction","volume":"26","author":"Lopaschuk","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2025.01.029_bib43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00395-023-01020-2","article-title":"Stimulating cardiac glucose oxidation lessens the severity of heart failure in aged female mice","volume":"119","author":"Sun","year":"2024","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.cjca.2025.01.029_bib44","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1126\/science.abc8861","article-title":"Comprehensive quantification of fuel use by the failing and nonfailing human heart","volume":"370","author":"Murashige","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cjca.2025.01.029_bib45","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/cvr\/cvae006","article-title":"Mitochondrial fatty acid oxidation is the major source of cardiac adenosine triphosphate production in heart failure with preserved ejection fraction","volume":"120","author":"Sun","year":"2024","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2025.01.029_bib46","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1126\/science.1219855","article-title":"Mitochondrial fission, fusion, and stress","volume":"337","author":"Youle","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.cjca.2025.01.029_bib47","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1101\/gad.269894.115","article-title":"Mitochondrial biogenesis and dynamics in the developing and diseased heart","volume":"29","author":"Dorn","year":"2015","journal-title":"Genes Dev"},{"key":"10.1016\/j.cjca.2025.01.029_bib48","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/sj.emboj.7601963","article-title":"Fission and selective fusion govern mitochondrial segregation and elimination by autophagy","volume":"27","author":"Twig","year":"2008","journal-title":"EMBO J"},{"key":"10.1016\/j.cjca.2025.01.029_bib49","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1038\/s42255-023-00930-8","article-title":"Mitophagy in human health, ageing and disease","volume":"5","author":"Picca","year":"2023","journal-title":"Nat Metab"},{"key":"10.1016\/j.cjca.2025.01.029_bib50","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.2337\/diabetes.51.10.2944","article-title":"Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes","volume":"51","author":"Kelley","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.cjca.2025.01.029_bib51","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/MCB.05603-11","article-title":"Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle","volume":"32","author":"Jheng","year":"2012","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cjca.2025.01.029_bib52","doi-asserted-by":"crossref","first-page":"9602","DOI":"10.1002\/jcb.27068","article-title":"A high-fat diet impairs mitochondrial biogenesis, mitochondrial dynamics, and the respiratory chain complex in rat myocardial tissues","volume":"119","author":"Chen","year":"2018","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.cjca.2025.01.029_bib53","doi-asserted-by":"crossref","first-page":"E859","DOI":"10.1073\/pnas.1617288114","article-title":"Mitochondrial fusion dynamics is robust in the heart and depends on calcium oscillations and contractile activity","volume":"114","author":"Eisner","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cjca.2025.01.029_bib54","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/FJC.0000000000001414","article-title":"Txnip gene knockout ameliorated high-fat diet-induced cardiomyopathy via regulating mitochondria dynamics and fatty acid oxidation","volume":"81","author":"Li","year":"2023","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.cjca.2025.01.029_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201801322","article-title":"Increased dynamin-related protein 1\u2013dependent mitochondrial fission contributes to high-fat-diet-induced cardiac dysfunction and insulin resistance by elevating tafazzin in mouse hearts","volume":"63","author":"Chang","year":"2019","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.cjca.2025.01.029_bib56","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/CIRCRESAHA.123.324103","article-title":"Blunted cardiac mitophagy in response to metabolic stress contributes to HFpEF","volume":"135","author":"Yoshii","year":"2024","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2025.01.029_bib57","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1161\/CIRCRESAHA.121.319377","article-title":"Alternative mitophagy protects the heart against obesity-associated cardiomyopathy","volume":"129","author":"Tong","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2025.01.029_bib58","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13148-015-0093-1","article-title":"Insulin resistance is associated with epigenetic and genetic regulation of mitochondrial DNA in obese humans","volume":"7","author":"Zheng","year":"2015","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.cjca.2025.01.029_bib59","doi-asserted-by":"crossref","first-page":"E818","DOI":"10.1152\/ajpendo.00322.2004","article-title":"Effects of weight loss and physical activity on skeletal muscle mitochondrial function in obesity","volume":"288","author":"Menshikova","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.cjca.2025.01.029_bib60","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002555","article-title":"Mitochondrial reactive oxygen species mediate cardiac structural, functional, and mitochondrial consequences of diet-induced metabolic heart disease","volume":"5","author":"Sverdlov","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjca.2025.01.029_bib61","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.2337\/db07-0481","article-title":"Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins","volume":"56","author":"Boudina","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.cjca.2025.01.029_bib62","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.yjmcc.2014.07.018","article-title":"High fat, high sucrose diet causes cardiac mitochondrial dysfunction due in part to oxidative post-translational modification of mitochondrial complex II","volume":"78","author":"Sverdlov","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.cjca.2025.01.029_bib63","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.yjmcc.2015.05.012","article-title":"Antioxidant treatment normalizes mitochondrial energetics and myocardial insulin sensitivity independently of changes in systemic metabolic homeostasis in a mouse model of the metabolic syndrome","volume":"85","author":"Ilkun","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.cjca.2025.01.029_bib64","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.2337\/db12-0072","article-title":"GSH or palmitate preserves mitochondrial energetic\/redox balance, preventing mechanical dysfunction in metabolically challenged myocytes\/hearts from type 2 diabetic mice","volume":"61","author":"Tocchetti","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.cjca.2025.01.029_bib65","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.freeradbiomed.2021.11.007","article-title":"The role of mitochondrial reactive oxygen species in insulin resistance","volume":"179","author":"Ayer","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.cjca.2025.01.029_bib66","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bcp.2024.116185","article-title":"Transcriptional control of cardiac energy metabolism in health and disease: lessons from animal models","volume":"224","author":"Rubio-Tom\u00e1s","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cjca.2025.01.029_bib67","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1042\/BCJ20180617","article-title":"Allosteric, transcriptional and post-translational control of mitochondrial energy metabolism","volume":"476","author":"Karwi","year":"2019","journal-title":"Biochem J"},{"key":"10.1016\/j.cjca.2025.01.029_bib68","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.2337\/db07-0093","article-title":"Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents","volume":"56","author":"Turner","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.cjca.2025.01.029_bib69","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/cvr\/cvp017","article-title":"Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding","volume":"82","author":"Wright","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2025.01.029_bib70","doi-asserted-by":"crossref","first-page":"R212","DOI":"10.1152\/ajpregu.00367.2010","article-title":"Interactions between the consumption of a high-fat diet and fasting in the regulation of fatty acid oxidation enzyme gene expression: an evaluation of potential mechanisms","volume":"300","author":"Frier","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.cjca.2025.01.029_bib71","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1101\/sqb.2011.76.011965","article-title":"Transcriptional control of cardiac fuel metabolism and mitochondrial function","volume":"76","author":"Leone","year":"2011","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.1016\/j.cjca.2025.01.029_bib72","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3803\/EnM.2015.30.4.557","article-title":"Diastolic dysfunction induced by a high-fat diet is associated with mitochondrial abnormality and adenosine triphosphate levels in rats","volume":"30","author":"Kang","year":"2015","journal-title":"Endocrinol Metab"},{"key":"10.1016\/j.cjca.2025.01.029_bib73","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.yjmcc.2011.10.010","article-title":"The transcriptional coactivators, PGC-1\u03b1 and \u03b2, cooperate to maintain cardiac mitochondrial function during the early stages of insulin resistance","volume":"52","author":"Mitra","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.cjca.2025.01.029_bib74","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1113\/JP278006","article-title":"Essential role of the PGC-1\u03b1\/PPAR\u03b2 axis in Ucp3 gene induction","volume":"597","author":"Lima","year":"2019","journal-title":"J Physiol"},{"key":"10.1016\/j.cjca.2025.01.029_bib75","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.2337\/diabetes.54.12.3496","article-title":"Plasma free fatty acids and peroxisome proliferator-activated receptor alpha in the control of myocardial uncoupling protein levels","volume":"54","author":"Murray","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.cjca.2025.01.029_bib76","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1161\/CIRCULATIONAHA.105.554360","article-title":"Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity","volume":"112","author":"Boudina","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.01.029_bib77","doi-asserted-by":"crossref","first-page":"48534","DOI":"10.1074\/jbc.M308529200","article-title":"Superoxide activates uncoupling proteins by generating carbon-centered radicals and initiating lipid peroxidation: studies using a mitochondria-targeted spin trap derived from alpha-phenyl-N-tert-butylnitrone","volume":"278","author":"Murphy","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cjca.2025.01.029_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/jpps.2024.13080","article-title":"The role of acetylation in obesity-induced cardiac metabolic alterations","volume":"27","author":"Ketema","year":"2024","journal-title":"J Pharm Pharm Sci"},{"key":"10.1016\/j.cjca.2025.01.029_bib79","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41580-018-0081-3","article-title":"Functions and mechanisms of non-histone protein acetylation","volume":"20","author":"Narita","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.cjca.2025.01.029_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.723996","article-title":"Post-translational acetylation control of cardiac energy metabolism","volume":"8","author":"Ketema","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cjca.2025.01.029_bib81","doi-asserted-by":"crossref","first-page":"297","DOI":"10.14348\/molcells.2015.0020","article-title":"Is acetylation a metabolic rheostat that regulates skeletal muscle insulin action?","volume":"38","author":"LaBarge","year":"2015","journal-title":"Mol Cells"},{"key":"10.1016\/j.cjca.2025.01.029_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagrm.2021.194691","article-title":"Aberrant gene expression induced by a high fat diet is linked to H3K9 acetylation in the promoter-proximal region","volume":"1864","author":"Morral","year":"2021","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"10.1016\/j.cjca.2025.01.029_bib83","article-title":"Obesity-mediated regulation of cardiac protein acetylation: parallel analysis of total and acetylated proteins via TMT-tagged mass spectrometry","volume":"38","author":"Romanick Samantha","year":"2018","journal-title":"Biosci Rep"},{"key":"10.1016\/j.cjca.2025.01.029_bib84","first-page":"183","article-title":"Advances and challenges of HDAC inhibitors in cancer therapeutics","volume":"138","author":"McClure","year":"2018"},{"key":"10.1016\/j.cjca.2025.01.029_bib85","doi-asserted-by":"crossref","first-page":"H265","DOI":"10.1152\/ajpheart.00752.2016","article-title":"Acetylation of mitochondrial proteins by GCN5L1 promotes enhanced fatty acid oxidation in the heart","volume":"313","author":"Thapa","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cjca.2025.01.029_bib86","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCULATIONAHA.105.559724","article-title":"Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding","volume":"113","author":"Kee","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.01.029_bib87","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.15415","article-title":"GCN5L1 impairs diastolic function in mice exposed to a high fat diet by restricting cardiac pyruvate oxidation","volume":"10","author":"Thapa","year":"2022","journal-title":"Physiol Rep"},{"key":"10.1016\/j.cjca.2025.01.029_bib88","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1074\/jbc.M116.753509","article-title":"Decreased mitochondrial pyruvate transport activity in the diabetic heart: role of mitochondrial pyruvate carrier 2 (MPC2) acetylation","volume":"292","author":"Vadvalkar","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cjca.2025.01.029_bib89","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.2337\/db12-1650","article-title":"Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation","volume":"62","author":"Jing","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.cjca.2025.01.029_bib90","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev.med.53.082901.104057","article-title":"Lipotoxic diseases","volume":"53","author":"Unger","year":"2002","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.cjca.2025.01.029_bib91","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1161\/CIRCRESAHA.116.306842","article-title":"Lipid use and misuse by the heart","volume":"118","author":"Schulze","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2025.01.029_bib92","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1113\/JP276747","article-title":"Cardiomyopathy in obesity, insulin resistance and diabetes","volume":"598","author":"Nakamura","year":"2020","journal-title":"J Physiol"},{"key":"10.1016\/j.cjca.2025.01.029_bib93","first-page":"18","article-title":"Lipotoxicity in obesity and diabetes-related cardiac dysfunction","volume":"10","author":"Zlobine","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cjca.2025.01.029_bib94","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2337\/db24-0240","article-title":"PAK3 exacerbates cardiac lipotoxicity via SREBP1c in obesity cardiomyopathy","volume":"73","author":"Chen","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.cjca.2025.01.029_bib95","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2337\/diabetes.53.7.1655","article-title":"Enhanced sarcolemmal FAT\/CD36 content and triacylglycerol storage in cardiac myocytes from obese Zucker rats","volume":"53","author":"Coort","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.cjca.2025.01.029_bib96","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/01.RES.0000154079.20681.B9","article-title":"Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy","volume":"96","author":"Chiu","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2025.01.029_bib97","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.micron.2007.11.002","article-title":"Intracardiac lipid accumulation, lipoatrophy of muscle cells and expansion of myocardial infarction in type 2 diabetic patients","volume":"39","author":"Borisov","year":"2008","journal-title":"Micron"},{"key":"10.1016\/j.cjca.2025.01.029_bib98","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1096\/fj.201601156R","article-title":"Ceramides and mitochondrial fatty acid oxidation in obesity","volume":"31","author":"Fucho","year":"2017","journal-title":"Faseb J"},{"key":"10.1016\/j.cjca.2025.01.029_bib99","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.hfc.2012.06.003","article-title":"Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure","volume":"8","author":"Park","year":"2012","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.cjca.2025.01.029_bib100","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.cmet.2012.03.005","article-title":"Diacylglycerol activation of protein kinase C\u03b5 and hepatic insulin resistance","volume":"15","author":"Jornayvaz","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.cjca.2025.01.029_bib101","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cjca.2025.01.029_bib102","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.celrep.2024.114746","article-title":"Ceramide synthesis inhibitors prevent lipid-induced insulin resistance through the DAG-PKC\u03b5-insulin receptor(T1150) phosphorylation pathway","volume":"43","author":"Xu","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.cjca.2025.01.029_bib103","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41569-021-00536-1","article-title":"Ceramides and other sphingolipids as drivers of cardiovascular disease","volume":"18","author":"Choi","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cjca.2025.01.029_bib104","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","article-title":"Epicardial adipose tissue in contemporary cardiology","volume":"19","author":"Iacobellis","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cjca.2025.01.029_bib105","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.numecd.2014.01.019","article-title":"Epicardial fat, rather than pericardial fat, is independently associated with diastolic filling in subjects without apparent heart disease","volume":"24","author":"Dabbah","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.cjca.2025.01.029_bib106","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1440-1681.2011.05601.x","article-title":"Human epicardial fat: what is new and what is missing?","volume":"38","author":"Sacks","year":"2011","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.cjca.2025.01.029_bib107","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.jacc.2018.03.509","article-title":"Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium","volume":"71","author":"Packer","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.01.029_bib108","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.atherosclerosis.2007.08.016","article-title":"Quantification of epicardial and peri-coronary fat using cardiac computed tomography; reproducibility and relation with obesity and metabolic syndrome in patients suspected of coronary artery disease","volume":"197","author":"Gorter","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cjca.2025.01.029_bib109","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/ncpcardio0319","article-title":"Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart","volume":"2","author":"Iacobellis","year":"2005","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.cjca.2025.01.029_bib110","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4093\/dmj.2015.39.5.405","article-title":"Increased epicardial adipose tissue thickness in type 2 diabetes mellitus and obesity","volume":"39","author":"Hong","year":"2015","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.cjca.2025.01.029_bib111","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/oby.2008.6","article-title":"Threshold values of high-risk echocardiographic epicardial fat thickness","volume":"16","author":"Iacobellis","year":"2008","journal-title":"Obesity"},{"key":"10.1016\/j.cjca.2025.01.029_bib112","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.amjcard.2010.01.368","article-title":"Relation of echocardiographic epicardial fat thickness and myocardial fat","volume":"105","author":"Malavazos","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2025.01.029_bib113","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1365-2265.2008.03411.x","article-title":"Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis","volume":"70","author":"Wang","year":"2009","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.cjca.2025.01.029_bib114","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1038\/oby.2008.379","article-title":"Epicardial adipose tissue extent: relationship with age, body fat distribution, and coronaropathy","volume":"16","author":"Silaghi","year":"2008","journal-title":"Obesity"},{"key":"10.1016\/j.cjca.2025.01.029_bib115","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.amjcard.2004.06.075","article-title":"Relation between epicardial adipose tissue and left ventricular mass","volume":"94","author":"Iacobellis","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2025.01.029_bib116","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.amjcard.2011.01.027","article-title":"Quantitative analysis of quantity and distribution of epicardial adipose tissue surrounding the left atrium in patients with atrial fibrillation and effect of recurrence after ablation","volume":"107","author":"Tsao","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2025.01.029_bib117","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/jcmm.14758","article-title":"Proteomics of epicardial adipose tissue in patients with heart failure","volume":"24","author":"Zhao","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.cjca.2025.01.029_bib118","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0305-0491(89)90337-4","article-title":"Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties","volume":"94","author":"Marchington","year":"1989","journal-title":"Comp Biochem Physiol B"},{"key":"10.1016\/j.cjca.2025.01.029_bib119","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.carpath.2008.02.006","article-title":"Presence of fatty-acid-binding protein 4 expression in human epicardial adipose tissue in metabolic syndrome","volume":"17","author":"Vural","year":"2008","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.cjca.2025.01.029_bib120","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1152\/ajpendo.00384.2015","article-title":"Glucose uptake and lipid metabolism are impaired in epicardial adipose tissue from heart failure patients with or without diabetes","volume":"310","author":"Burgeiro","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.cjca.2025.01.029_bib121","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10741-012-9337-8","article-title":"Direct effects of adipokines on the heart: focus on adiponectin","volume":"18","author":"Park","year":"2013","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cjca.2025.01.029_bib122","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/CIRCRESAHA.120.314458","article-title":"Adiponectin, leptin and cardiovascular disorders","volume":"128","author":"Zhao","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2025.01.029_bib123","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cardiores.2007.04.011","article-title":"Globular and full-length forms of adiponectin mediate specific changes in glucose and fatty acid uptake and metabolism in cardiomyocytes","volume":"75","author":"Palanivel","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2025.01.029_bib124","doi-asserted-by":"crossref","first-page":"44320","DOI":"10.1074\/jbc.M400347200","article-title":"gAd-globular head domain of adiponectin increases fatty acid oxidation in newborn rabbit hearts","volume":"279","author":"Onay-Besikci","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cjca.2025.01.029_bib125","first-page":"2904","article-title":"Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone","volume":"82","author":"Blum","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cjca.2025.01.029_bib126","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1463-1326.2006.00653.x","article-title":"Modulation of central leptin sensitivity and energy balance in a rat model of diet-induced obesity","volume":"9","author":"Fam","year":"2007","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.cjca.2025.01.029_bib127","doi-asserted-by":"crossref","first-page":"29424","DOI":"10.1074\/jbc.M203813200","article-title":"Leptin activates cardiac fatty acid oxidation independent of changes in the AMP-activated protein kinase-acetyl-CoA carboxylase-malonyl-CoA axis","volume":"277","author":"Atkinson","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cjca.2025.01.029_bib128","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/FJC.0b013e31820014f9","article-title":"Intracerebroventricular leptin administration differentially alters cardiac energy metabolism in mice fed a low-fat and high-fat diet","volume":"57","author":"Keung","year":"2011","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.cjca.2025.01.029_bib129","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.metabol.2006.03.020","article-title":"Distinct effects of short- and long-term leptin treatment on glucose and fatty acid uptake and metabolism in HL-1 cardiomyocytes","volume":"55","author":"Palanivel","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/j.cjca.2025.01.029_bib130","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.2337\/diabetes.51.8.2587","article-title":"Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart","volume":"51","author":"Young","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.cjca.2025.01.029_bib131","doi-asserted-by":"crossref","first-page":"40567","DOI":"10.1074\/jbc.M100052200","article-title":"Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats","volume":"276","author":"Luiken","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cjca.2025.01.029_bib132","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1006\/cimm.1999.1490","article-title":"Human leptin stimulates proliferation and activation of human circulating monocytes","volume":"194","author":"Santos-Alvarez","year":"1999","journal-title":"Cell Immunol"},{"key":"10.1016\/j.cjca.2025.01.029_bib133","doi-asserted-by":"crossref","first-page":"8","DOI":"10.12997\/jla.2021.10.1.8","article-title":"Impact of obesity-related inflammation on cardiac metabolism and function","volume":"10","author":"Larsen","year":"2021","journal-title":"J Lipid Atheroscler"},{"key":"10.1016\/j.cjca.2025.01.029_bib134","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1210\/endrev\/bnad036","article-title":"Endotrophin, a key marker and driver for fibroinflammatory disease","volume":"45","author":"Henriksen","year":"2023","journal-title":"Endocr Rev"},{"key":"10.1016\/j.cjca.2025.01.029_bib135","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1172\/JCI63930","article-title":"Adipocyte-derived endotrophin promotes malignant tumor progression","volume":"122","author":"Park","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cjca.2025.01.029_bib136","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200091","article-title":"Endotrophin, a collagen VI formation\u2013derived peptide, in heart failure","volume":"1","author":"Chirinos","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.cjca.2025.01.029_bib137","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1038\/ncomms4485","article-title":"Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction","volume":"5","author":"Sun","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.cjca.2025.01.029_bib138","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00125-016-4094-1","article-title":"Serum endotrophin identifies optimal responders to PPAR\u03b3 agonists in type 2 diabetes","volume":"60","author":"Karsdal","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.cjca.2025.01.029_bib139","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","article-title":"Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors: a state-of-the-art review","volume":"5","author":"Lopaschuk","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.cjca.2025.01.029_bib140","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/obr.12841","article-title":"Weight loss variability with SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes mellitus and obesity: mechanistic possibilities","volume":"20","author":"Brown","year":"2019","journal-title":"Obes Rev"},{"key":"10.1016\/j.cjca.2025.01.029_bib141","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-24-0011","article-title":"Incretin-mediated control of cardiac energy metabolism","volume":"263","author":"Chan","year":"2024","journal-title":"J Endocrinol"},{"key":"10.1016\/j.cjca.2025.01.029_bib142","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41569-023-00849-3","article-title":"Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action","volume":"20","author":"Ussher","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cjca.2025.01.029_bib143","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.01.029_bib144","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0140-6736(24)00469-0","article-title":"Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials","volume":"403","author":"Butler","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2025.01.029_bib145","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","article-title":"Semaglutide 2\u00b74 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial","volume":"397","author":"Davies","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2025.01.029_bib146","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","article-title":"Semaglutide in patients with obesity-related heart failure and type 2 diabetes","volume":"390","author":"Kosiborod","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.01.029_bib147","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.01.029_bib148","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.01.029_bib149","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1161\/01.CIR.0000139339.85840.DD","article-title":"Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy","volume":"110","author":"Nikolaidis","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.01.029_bib150","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1371\/journal.pone.0023570","article-title":"Albiglutide, a long lasting glucagon-like peptide-1 analog, protects the rat heart against ischemia\/reperfusion injury: evidence for improving cardiac metabolic efficiency","volume":"6","author":"Bao","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2025.01.029_bib151","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1124\/jpet.106.100982","article-title":"Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts","volume":"317","author":"Zhao","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cjca.2025.01.029_bib152","first-page":"140","article-title":"The GLP-1 receptor agonist liraglutide increases myocardial glucose oxidation rates via indirect mechanisms and mitigates experimental diabetic cardiomyopathy","volume":"37","author":"Almutairi","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.01.029_bib153","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130894","article-title":"Cardioprotection resulting from glucagon-like peptide-1 administration involves shifting metabolic substrate utilization to increase energy efficiency in the rat heart","volume":"10","author":"Aravindhan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2025.01.029_bib154","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1172\/JCI99934","article-title":"Cardioprotective GLP-1 metabolite prevents ischemic cardiac injury by inhibiting mitochondrial trifunctional protein-\u03b1","volume":"130","author":"Siraj","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cjca.2025.01.029_bib155","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ebiom.2017.05.028","article-title":"SGLT2 inhibition by empagliflozin promotes fat utilization and browning and attenuates inflammation and insulin resistance by polarizing M2 macrophages in diet-induced obese mice","volume":"20","author":"Xu","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cjca.2025.01.029_bib156","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s00125-022-05851-x","article-title":"Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis","volume":"66","author":"Radlinger","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.cjca.2025.01.029_bib157","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jacbts.2018.07.006","article-title":"Empagliflozin increases cardiac energy production in diabetes: novel translational insights into the heart failure benefits of SGLT2 inhibitors","volume":"3","author":"Verma","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.cjca.2025.01.029_bib158","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/j.jacc.2019.01.056","article-title":"Empagliflozin ameliorates adverse left ventricular remodeling in nondiabetic heart failure by enhancing myocardial energetics","volume":"73","author":"Santos-Gallego","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.01.029_bib159","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.2337\/db15-1356","article-title":"Shift to fatty substrate utilization in response to sodium-glucose cotransporter 2 inhibition in subjects without diabetes and patients with type 2 diabetes","volume":"65","author":"Ferrannini","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.cjca.2025.01.029_bib160","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.2337\/dc15-2688","article-title":"Dapagliflozin enhances fat oxidation and ketone production in patients with type 2 diabetes","volume":"39","author":"Daniele","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cjca.2025.01.029_bib161","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/obr.12755","article-title":"Weight loss associated with sodium-glucose cotransporter-2 inhibition: a review of evidence and underlying mechanisms","volume":"19","author":"Lee","year":"2018","journal-title":"Obes Rev"},{"key":"10.1016\/j.cjca.2025.01.029_bib162","first-page":"20","article-title":"Targeting fatty acid and carbohydrate oxidation\u2014a novel therapeutic intervention in the ischemic and failing heart","volume":"7","author":"Jaswal","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cjca.2025.01.029_bib163","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/01.RES.0000129255.19569.8f","article-title":"Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation","volume":"94","author":"Dyck","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2025.01.029_bib164","doi-asserted-by":"crossref","first-page":"H2304","DOI":"10.1152\/ajpheart.00599.2005","article-title":"Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia","volume":"289","author":"Stanley","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cjca.2025.01.029_bib165","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.RES.86.5.580","article-title":"The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase","volume":"86","author":"Kantor","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2025.01.029_bib166","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1586\/14779072.5.6.1123","article-title":"Metabolic therapy for the treatment of ischemic heart disease: reality and expectations","volume":"5","author":"Wang","year":"2007","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.cjca.2025.01.029_bib167","first-page":"838","article-title":"Metabolic modulators in heart disease: past, present, and future","volume":"33","author":"Lopaschuk","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.01.029_bib168","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1111\/jcmm.15180","article-title":"Cardiac metabolism as a driver and therapeutic target of myocardial infarction","volume":"24","author":"Zuurbier","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.cjca.2025.01.029_bib169","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ijcard.2014.10.149","article-title":"The efficacy of trimetazidine on stable angina pectoris: a meta-analysis of randomized clinical trials","volume":"177","author":"Peng","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2025.01.029_bib170","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jacc.2006.03.060","article-title":"A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure","volume":"48","author":"Fragasso","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.01.029_bib171","doi-asserted-by":"crossref","first-page":"e02","DOI":"10.15420\/ecr.2022.10","article-title":"Efficacy of ranolazine to improve diastolic performance in heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"18","author":"Putri","year":"2023","journal-title":"Eur Cardiol"},{"key":"10.1016\/j.cjca.2025.01.029_bib172","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00395-009-0003-9","article-title":"Targeting malonyl CoA inhibition of mitochondrial fatty acid uptake as an approach to treat cardiac ischemia\/reperfusion","volume":"104","author":"Ussher","year":"2009","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.cjca.2025.01.029_bib173","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1161\/CIRCULATIONAHA.106.642009","article-title":"Absence of malonyl coenzyme A decarboxylase in mice increases cardiac glucose oxidation and protects the heart from ischemic injury","volume":"114","author":"Dyck","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.01.029_bib174","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCULATIONAHA.121.058740","article-title":"Glucose-insulin-potassium therapy for acute myocardial infarction: 50 years on and time for a relook","volume":"146","author":"Udelson","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.01.029_bib175","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/cvr\/cvs129","article-title":"Stimulation of glucose oxidation protects against acute myocardial infarction and reperfusion injury","volume":"94","author":"Ussher","year":"2012","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2025.01.029_bib176","first-page":"H1079","article-title":"Dichloroacetate stimulation of glucose oxidation improves recovery of ischemic rat hearts","volume":"259","author":"McVeigh","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cjca.2025.01.029_bib177","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00005344-199803000-00002","article-title":"Effects of dichloroacetate on mechanical recovery and oxidation of physiologic substrates after ischemia and reperfusion in the isolated heart","volume":"31","author":"Barak","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.cjca.2025.01.029_bib178","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s44161-023-00259-1","article-title":"Ketones and the cardiovascular system","volume":"2","author":"Lopaschuk","year":"2023","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.cjca.2025.01.029_bib179","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1161\/CIRCULATIONAHA.118.036459","article-title":"Cardiovascular effects of treatment with the ketone body 3-hydroxybutyrate in chronic heart failure patients","volume":"139","author":"Nielsen","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.01.029_bib180","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124079","article-title":"The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense","volume":"4","author":"Horton","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.cjca.2025.01.029_bib181","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1002\/ehf2.13634","article-title":"Chronic exogenous ketone supplementation blunts the decline of cardiac function in the failing heart","volume":"8","author":"Takahara","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cjca.2025.01.029_bib182","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007684","article-title":"Ketone ester treatment improves cardiac function and reduces pathologic remodeling in preclinical models of heart failure","volume":"14","author":"Yurista","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2025.01.029_bib183","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.metabol.2020.154452","article-title":"Myocardial ketone body utilization in patients with heart failure: the impact of oral ketone ester","volume":"115","author":"Monzo","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.cjca.2025.01.029_bib184","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.124.069732","article-title":"Randomized crossover trial of 2-week ketone ester treatment in patients with type 2 diabetes and heart failure with preserved ejection fraction","volume":"150","author":"Gopalasingam","year":"2024","journal-title":"Circulation"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X25000996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X25000996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T23:58:38Z","timestamp":1765324718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X25000996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":184,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0828282X25000996"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2025.01.029","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Impact of Obesity on Cardiac Energy Metabolism and Efficiency in Heart Failure With Preserved Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2025.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}